Viewing Study NCT06309511



Ignite Creation Date: 2024-05-06 @ 8:14 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06309511
Status: RECRUITING
Last Update Posted: 2024-03-13
First Post: 2024-03-07

Brief Title: Subendocardial Viability Ratio in Hypertension
Sponsor: Istituto Auxologico Italiano
Organization: Istituto Auxologico Italiano

Study Overview

Official Title: Subendocardial Viability Ratio in Hypertension
Status: RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SEVR-HT
Brief Summary: The aim of the research is to evaluate the Subendocardial Viability Ratio SEVR in hypertensive patients using non-invasive arterial tonometry and to establish the influencing factors and the possibility of predicting cardiovascular morbidity and mortality in arterial hypertension

The SEVR will be evaluated on all patients belonging to the Arterial Hypertension Centers undergoing non-invasive arterial tonometry

The SEVR is calculated on the morphology of the central pressure wave as the ratio between the DPTI diastolic pressure-time index ie the area between the carotid pressure curve and the ventricular pressure curve during the diastolic phase and the SPTI systolic pressure-time index ie the area under the carotid pressure curve during the systolic phase

The SEVR will be correlated with the anthropometric and pathology variables which will be collected in an appropriate database
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None